Aixtron Gets a Vote of Confidence from Renesas, Even as Analysts Hit the Brakes

Aixtron delivers GaN systems to Renesas, lifting revenue guidance, but analysts warn shares have outpaced fundamentals after a 290% yearly gain.

The German semiconductor equipment maker Aixtron has found itself in an unusual position: its order book is thickening, its stock is trading near multi-year highs, and yet a growing chorus of analysts is telling clients to take profits. The latest development — a GaN equipment delivery to Renesas — underscores the operational momentum, but the share price may already be pricing in more than the numbers can deliver.

Renesas has taken delivery of multiple Aixtron Planetary G5+C systems and has already put them into production. The tools are being used to scale high-volume manufacturing of gallium nitride power devices, a segment that Rohan Samsi, Renesas’s vice president of GaN business, described as “one of the fastest-growing” in the industry. The order builds on the Planetary platform originally deployed at Transphorm, which Renesas acquired in 2024.

For Aixtron, the timing is critical. In the first quarter of 2026, GaN accounted for just 3 percent of equipment revenue, while optoelectronics swallowed nearly 70 percent of incoming orders. The company itself had flagged that a GaN recovery would not materialize until later in the year. This deal suggests the rebound may be arriving ahead of schedule.

The broader picture has brightened considerably. First-quarter order intake climbed to around €171 million, up from €132 million a year earlier, prompting Aixtron to lift its full-year revenue guidance to roughly €560 million, compared with a previous target of €520 million. Second-quarter sales are expected to come in at about €110 million, as larger system deliveries begin to ramp. A recovery in the silicon carbide segment, however, is not anticipated until the second half of 2026 or early 2027.

The stock has been on a tear. Since the start of the year, Aixtron shares have surged roughly 160 percent, closing at €50.82 — just shy of the 52-week high of €50.96. Over twelve months, the gain is nearly 290 percent. That kind of performance has made some investors jittery about valuation, and it has prompted at least one prominent sell-side firm to change its tune.

Berenberg analyst Gustav Froberg downgraded the stock from “Buy” to “Hold” on Wednesday, even as he raised his price target from €31 to €42. The message was clear: the company’s prospects are improving, but the share price has run too far, too fast. Froberg lifted his revenue estimates for 2026 and 2027 by 9 to 13 percent, and his EBIT forecasts by 20 to 24 percent. Even so, he sees limited upside from current levels — the new target sits well below the prevailing market price.

The disconnect between the stock and the underlying financials is stark. First-quarter revenue collapsed to €59 million, a drop of nearly 47 percent year-on-year, and the company posted a loss per share of €0.19, compared with a small profit in the prior-year period. The market is betting on the future: optoelectronics revenue is expected to double to €243 million in 2026, and management has proposed a dividend of €0.185 per share for the fiscal year, signaling confidence despite the weak start.

Analyst sentiment is split. Jefferies and JP Morgan maintain Buy ratings with price targets of €55 each. But the consensus is more cautious. The DZ Bank rates the stock a Hold with a €45 target, Deutsche Bank a Hold at €43, UBS a Neutral at €50, and Barclays an Equal Weight at €39. The average target sits at roughly €43 — about 14 percent below the current share price.

Aixtron will report second-quarter results on July 30. By then, investors will have a clearer view of whether the operational recovery that the market has been discounting for months is actually taking hold. The Renesas order suggests GaN is gaining traction earlier than expected, which could give the company a second growth pillar alongside its robust optoelectronics pipeline. Whether that is enough to justify the stock’s current altitude is another question entirely.